kesimpta 20 mg/0.4 ml rastvor za injekciju u napunjenom penu
novartis ba d.o.o. - ofatumumab - rastvor za injekciju u napunjenom penu - 20 mg/0.4 ml - 1 napunjeni pen sadrži 20 mg ofatumumaba u 0,4 ml rastvora za injekciju (50 mg/ml)
beovu 120 mg/1 ml rastvor za injekciju u napunjenom špricu
novartis ba d.o.o. - brolucizumab - rastvor za injekciju u napunjenom špricu - 120 mg/1 ml - jedna napunjena šprica sadrži 19,8 mg brolucizumaba u 0,165 ml rastvora
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).
nevanac
novartis europharm limited - nepafenaka - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
hirobriz breezhaler
novartis europharm limited - indakaterol maleat - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - hirobriz breezhaler je indiciran za liječenje bronhodilatatora kod opstrukcije protoka zraka kod odraslih osoba s kroničnom opstruktivnom plućnom bolesti.
zomarist
novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.